🇺🇸 FDA
Pipeline program

telavancin

9809-CL-1407

Phase 1 small_molecule completed

Quick answer

telavancin for Kidney Diseases is a Phase 1 program (small_molecule) at CUMBERLAND PHARMACEUTICALS INC with 1 ClinicalTrials.gov record(s).

Program details

Company
CUMBERLAND PHARMACEUTICALS INC
Indication
Kidney Diseases
Phase
Phase 1
Modality
small_molecule
Status
completed

Clinical trials